Chemcon Specialty Chemicals in FY26: Strong Q4 rebound, margins still under pressure

Chemcon Specialty Chemicals closed FY26 with a sharp improvement in the March quarter, even as full-year profitability stayed softer than the prior year. In Q4 FY26, revenue from operations rose to 75.4 crore, up 37% year on year and 32% sequentially from Q3 FY26. Profitability improved alongside volumes, with Q4 EBITDA at 8.9 crore and PAT at 6.4 crore.

For the full year, revenue grew to 240.0 crore, a 16% increase over FY25. But EBITDA declined to 30.2 crore from 32.9 crore, and PAT slipped to 23.6 crore from 24.5 crore. Management attributed the uneven FY26 performance to subdued demand, pricing pressure across key products, geopolitical uncertainty, and crude oil price volatility.

Q4 bounce led by volumes and better realizations

The quarter stood out because both of Chemcon’s core segments improved. Management said the organic and inorganic chemicals businesses delivered better performance on higher volumes and improved realizations across key products.

The disclosures support that volume trend. Total sales volume rose to 3,497 MT in Q4 FY26 from 2,338 MT in Q3 FY26 and 2,210 MT in Q4 FY25. Export contribution also strengthened, moving to 47% of Q4 revenue, compared with 45% in Q3 and 39% in Q4 FY25.

Chemcon also highlighted traction in newer organic products such as Bromobenzene and 2 Bromo, which it said received encouraging response from end-user industries including pharmaceuticals, agrochemicals, and aromatic chemicals.

Financial snapshot

Segment mix: organic remains the revenue engine

Chemcon operates across organic chemicals and inorganic bromides, with a small others bucket. In FY26, organic chemicals contributed 74% of revenue, inorganic chemicals 20%, and others 6%. In absolute terms, the company disclosed FY26 revenue of 178 crore from organic chemicals, 49 crore from inorganic chemicals, and 13 crore from others.

This mix has stayed organic-heavy in recent years, and the Q4 mix was similar: organic 71%, inorganic 24%, others 5%.

A key theme in the company’s long-term narrative is moving up the value chain. It disclosed that organic chemicals revenue increased from 46 crore in FY15 to 178 crore in FY26. Inorganic chemicals grew from 13 crore to 49 crore over the same period, while total revenue rose from 64 crore to 240 crore.

Acquisition-driven push to broaden the inorganic platform

A major strategic development in the presentation is the acquisition of Shivam Petrochem Industries via a slump sale for 36.00 crore. The presentation specifies that Shivam Petrochem is a partnership firm and a related party, and the transaction is subject to necessary approvals.

Management said the acquisition is progressing well, with integration activities and license transfers nearing completion. The acquired business is expected to begin contributing to revenues in the coming quarters. Chemcon positions this deal as a way to expand its presence across bulk drugs, chemical intermediates, solvents, and specialty chemicals, while unlocking cost efficiencies and adding technical know-how.

Chemcon also disclosed Shivam Petrochem’s annual turnover trend: 3 crore in FY23, 10 crore in FY24, and 26 crore in FY25. The presentation lists several products under Shivam Petrochem’s portfolio, indicating an intent to add a new range of intermediates to the combined offering.

Capacity base, export footprint, and customer concentration

Chemcon’s facilities are located near Manjusar, Vadodara, Gujarat. The presentation states the company has 9 operational plants and 6 owned warehouses. Installed capacity is disclosed as 11,400 MTPA for organic chemicals and related products (HMDS, CMIC, Bromobenzene, 2 Bromo and ancillary products) and 15,000 MTPA for inorganic bromides.

It also lists two proposed expansion units, P-10 and P-11, with a timeline of Q1 FY27e.

The export footprint is meaningful, with FY26 exports at about 41% of revenue. Key countries listed include the United States, Italy, South Korea, Germany, China, Japan, UAE, Russia, Spain, Thailand, and Malaysia.

On the customer side, the company disclosed that the top 5 customers contribute about 32% of revenue and the top 10 contribute about 48%. This provides visibility into concentration risk even as the company emphasizes long-standing relationships.

Balance sheet and cash flow: operating cash positive, investments rising

In FY26, net cash from operating activities was 41.5 crore, up from 38.3 crore in FY25. Investing cash outflow increased to 35.3 crore from 16.7 crore, indicating a heavier investment phase.

As of March 2026, total assets were 568.0 crore. Current borrowings rose to 53.1 crore at March 2026 from 24.5 crore at March 2025, while cash and cash equivalents were 10.4 crore. The company also reported bank balances of 178.2 crore.

What stands out from FY26

Chemcon’s FY26 message is best understood in two layers. The first is the visible Q4 recovery, supported by higher volumes, improved realizations, and stronger export contribution. The second is the full-year margin compression, which management linked to pricing pressure and demand softness.

The company is trying to reduce dependence on a narrow set of molecules by adding newer products and by acquiring Shivam Petrochem’s intermediates portfolio. The success of this strategy will depend on execution: completing integration, translating capacity and product additions into steady volume growth, and restoring margins closer to earlier levels.

For investors, FY26 provides a clear near-term takeaway. Demand and pricing cycles can weigh on profitability even when revenue grows. Chemcon’s response is to broaden its product offering and expand capacity, while leaning into exports and long-standing customer relationships.